High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment? - Espinosa-Cárdenas E; Sánchez-García M; Ramírez-Rentería C; Mendoza-Zubieta V; Sosa-Eroza E; Mercado M (Endocrine, 2020)